Chart Update, page-24467

Found few interesting comments for you guys


"Managed to get out this morning without any damage. Not a good sign that the previously strong $2.10 - $2.12 support area has been broken. I don't think the fundamentals look too bad under $2.10 but the market doesn't think so at the moment. Might wait until the dust settles a bit..."

"Has it settled enough for you?...I got in at 1.95 today. Buyers are starting to look a bit sparse so may have a way to drop yet however."

"Yes that is a significant strong support that broke. It would scare me out as well"

"the reality doesnt match the chart? It must be annoying when that happens..sort of unsporting in a way. I find enough confusion as it is without letting excessive analysis make it worse. My hope is that it has a lot less distance to fall now than it has at any time in the last five years."

"Well it's a lot closer to zero now, so the fall couldn’t be that great. It's a real pity that a company with such great products, growth in sales and overall potential, has been such a consistently poor SP performer for such a long (more than 5 years) period of time."

"They should also perhaps stop issuing shares to staff every five minutes. The discount they offer them at would surely encourage staff to sell with little thought involved.My patience is wearing thin on this one. Watched it go sideways for years... a company really not realising anything close to its potential."

"It does make a profit. No one is saying it doesn't. The problem is the profit is not growing while you are paying a multiple for it that suggests it should be actually growing its profit at 5-10% every year."

"In theory they are in a growth industry and sales have performed OK - rising from $290m in 2006 when they earned $70m after tax to $467m in 2012. Sales growth has been flat the last four years. Profits were $64m, $6m less than 6 years ago. On the plus side, return on assets and equity remain fairly high and debts are modest. But with sales static and profits subdued, its hard to call it a compelling purchase. At 16 times earnings, for a company that has not demonstrated profitable growth, they are not screaming "buy me".My take is that they are cyclical currency play if the kiwi materially drops against major trading partners (particularly the greenback).They could also be a takeover target - the register is fairly open and global medical equipment makers could perhaps extract economies.Technically they look weak - you could have paid the same price back in 2003. Look for support around the current level or maybe $1.80 if that fails.Disc: Don't hold"


Does it remind you anything? Well, yes, that is FPH some years back. Just saying...